Lehigh Valley Cancer Institute 2018 Statistical Report
Lehigh Valley Cancer Institute annual statistical report provides information about cancer care delivered by Lehigh Valley Health Network, our technologies and the cancer care team that makes it possible.
Each year, Lehigh Valley Cancer Institute issues a statistical report about cancer care provided to patients in the communities we serve. Information includes types of cancers we treat, clinical research and clinical trials, as well as support services, our cancer care team and more.
Caring for Many
- We treated more than 3,500 patients in 2017.
- The most commonly treated cancers were breast, lung, colon-rectal, prostate, blood and bone marrow.
- Throughout 2017, we had more than 50 active clinical trials.
Disease Management Teams – Lehigh Valley Cancer Institute aligned with Memorial Sloan Kettering (MSK) Cancer Center to initiate site-specific disease management teams (DMTs). Each DMT is comprised of clinicians who specialize in a particular type of cancer care. Our clinical providers work closely with their MSK counterparts, including on individual patient cases.
Elite clinical trials – Lehigh Valley Cancer Institute offers access to many limited cancer clinical trials including new kidney cancer clinical trials
Revolutionizing melanoma care – Groundbreaking treatments for melanoma found only at Lehigh Valley Cancer Institute
Radiation immunotherapy – This precise technique enhances immune system response by ‘dose painting’ radiation at center of tumor.
Mobile mammography coach – Our new mammography coach debuted this year. This specially designed vehicle has the same breast imaging technology as offered by Breast Health Services, but in this case the imaging technology is placed inside a state-of-the-art mobile unit. With the mammography coach, we can bring screening mammogram to women around the region.